| Product NDC: | 0574-0014 | 
| Proprietary Name: | Erythra-Derm | 
| Non Proprietary Name: | Erythromycin | 
| Active Ingredient(s): | 20 mg/mL & nbsp; Erythromycin | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-0014 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA062687 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19880228 | 
| Package NDC: | 0574-0014-02 | 
| Package Description: | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE | 
| NDC Code | 0574-0014-02 | 
| Proprietary Name | Erythra-Derm | 
| Package Description | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE | 
| Product NDC | 0574-0014 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Erythromycin | 
| Dosage Form Name | SOLUTION | 
| Route Name | TOPICAL | 
| Start Marketing Date | 19880228 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | ERYTHROMYCIN | 
| Strength Number | 20 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |